Cough, Cold And Allergy (Hay Fever) Remedies in Norway
Euromonitor International's Cough, Cold And Allergy (Hay Fever) Remedies in Norway market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.
Buy online to access strategic market analysis and an interactive statistical database of volume and value market sizes, company and brand shares, distribution and pricing data.
Tables: 39 | Publication date: Jun 2009
Why buy this report
- Get insight into trends in market performance
- Pinpoint growth sectors and identify factors driving change
- Identify market and brand leaders and understand the competitive environment
Product coverage
Antihistamines/allergy remedies (systemic); Child-specific cough; cold and allergy remedies; Combination products - cough; cold and allergy (hay fever) remedies; Cough remedies; Decongestants; Medicated confectionery; Pharyngeal preparations
Table of contents
OTC HEALTHCARE IN NORWAY : MARKET INSIGHT
EXECUTIVE SUMMARY
OTC healthcare market characterised by preventative and simple remedies
Marketing plays critical role in selling products
Fragmentation characterises competitive environment
Pharmacies develop loyal and satisfied customer base
Moderate growth predicted over forecast period
KEY TRENDS AND DEVELOPMENTS
Brand dynamics become more important
Pharmacies have loyal and satisfied customers
Debate continues regarding price sensitivity of OTC healthcare products
Norwegians more open to self-medication
Online shopping on the horizon
MARKET INDICATORS
Table 1 Consumer Expenditure on Health Goods and Medical Services 2003-2008
Table 2 Life Expectancy at Birth 2003-2008
MARKET DATA
Table 3 Sales of OTC Healthcare by Sector: Value 2003-2008
Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
Table 5 OTC Healthcare Company Shares by Value 2004-2008
Table 6 OTC Healthcare Brand Shares by Value 2005-2008
Table 7 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008
Table 8 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008
Table 9 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
Table 10 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013
APPENDIX
OTC Registration and Classification
De-listing or de-reimbursement
Advertising
Packaging and labelling
Distribution
Vitamins & Dietary Supplements Registration and Classification
Self-medication and Preventative Medicine
Generics
Switches
Summary 1 OTC Healthcare Switches 2006-2008
DEFINITIONS
Summary 2 Research Sources
LOCAL COMPANY PROFILES - NORWAY
AXELLUS AS - OTC HEALTHCARE - NORWAY
STRATEGIC DIRECTION
KEY FACTS
Summary 3 Axellus AS : Key Facts
Summary 4 Axellus AS: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
Summary 5 Axellus AS: Production Statistics 2007
COMPETITIVE POSITIONING
Summary 6 Axellus AS: Competitive Position 2008
BRYNILD GRUPPEN AS - OTC HEALTHCARE - NORWAY
STRATEGIC DIRECTION
KEY FACTS
Summary 7 Brynild Gruppen AS: Key Facts
Summary 8 Brynild Gruppen AS: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 9 Brynild Gruppen AS : Competitive Position 2008
MIDELFART SONESSON AS - OTC HEALTHCARE - NORWAY
STRATEGIC DIRECTION
KEY FACTS
Summary 10 Midelfart Sonesson AS: Key Facts
Summary 11 Midelfart Sonesson AS: Operational Indicators
COMPANY BACKGROUND
COMPETITIVE POSITIONING
Summary 12 Midelfart Sonesson AS: Competitive Position 2008
NYCOMED PHARMA AS - OTC HEALTHCARE - NORWAY
STRATEGIC DIRECTION
KEY FACTS
Summary 13 Nycomed Pharma AS: Key Facts
Summary 14 Nycomed Pharma AS: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
Summary 15 Nycomed Pharma AS: Production Statistics 2007
COMPETITIVE POSITIONING
Summary 16 Nycomed Pharma AS: Competitive Position 2008
WEIFA AS - OTC HEALTHCARE - NORWAY
STRATEGIC DIRECTION
KEY FACTS
Summary 17 Weifa AS: Key Facts
Summary 18 Weifa AS: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
Summary 19 Weifa AS: Production Statistics 2007
COMPETITIVE POSITIONING
Summary 20 Weifa AS: Competitive Position 2008
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN NORWAY
HEADLINES
TRENDS
SWITCHES
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 11 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2003-2008
Table 12 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2003-2008
Table 13 Sales of Decongestants by Type: Value 2003-2008
Table 14 Sales of Decongestants by Type: % Value Growth 2003-2008
Table 15 Herbal vs Standard Cough, Cold and Allergy (Hay Fever) Remedies 2003-2008
Table 16 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2004-2008
Table 17 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2005-2008
Table 18 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2008-2013
Table 19 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2008-2013